Posts by Steven Kyle Grinspoon, MD
-
Diet Quality Is Suboptimal or Poor in Large Proportion of Global Population With HIV
Kathleen V. Fitch, MSN, a principal associate in medicine at Massachusetts General Hospital, Steven K. Grinspoon, MD, chief of the Metabolism Unit, and colleagues conducted the first analysis of diet in a global cohort of people with HIV infection and found diet quality was poor or suboptimal in 42% of individuals.
-
Preventing Heart Disease After HIV Infection
Research at Massachusetts General Hospital has led to several landmark studies, including the REPRIEVE trial, aimed at understanding and preventing HIV-related heart disease.
-
Treating Metabolic Disease in HIV Infection
Massachusetts General Hospital investigators have developed an effective drug, tesamorelin, to treat HIV lipodystrophy and non-alcoholic fatty liver disease.
-
Medical Grand Rounds: Obesity, Cardiovascular Disease and Metabolic Dysregulation in a Viral Pandemics: Prior Lessons and New Research Opportunities
In this Department of Medicine virtual Grand Rounds, Steven Grinspoon, MD, chief of the Metabolism Unit, presented on research findings related to obesity, cardiovascular disease and metabolic dysregulation during a viral pandemic.
-
Opinion: Cardiovascular disease is the next great challenge for HIV care
Cardiovascular (CV) disease is a leading cause of death of people with HIV. Dr. Steven Grinspoon calls for better understanding of the causes and highlights a promising trial.
Biography
Steven K. Grinspoon, MD is a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and a faculty member in the Neuroendocrine Unit at the Massachusetts General Hospital, and a Professor of Medicine at Harvard Medical School. He is a clinical researcher who studies hypothalamic control of body weight and fat distribution in obesity and lipodystrophy with a focus on the metabolic and cardiovascular consequences of visceral fat accumulation. Awards in recognition of his work have included selection to the American Society for Clinical Investigation, the Association of American Physicians and the 2014 Daniel Ahrens Award for Translational Science Research by the Association of Clinical and Translational Science. He is the author of more than 200 peer-reviewed publications and serves as the chief of Mass General's Metabolism Unit and the director of the Nutrition Obesity Research Center at Harvard.